LHC Group (LHCG) Issues Earnings Results

LHC Group (NASDAQ:LHCG) issued its quarterly earnings data on Monday. The health services provider reported $0.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.04, Bloomberg Earnings reports. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. During the same quarter in the previous year, the business earned $0.54 earnings per share. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis.

LHC Group (NASDAQ:LHCG) traded up $1.90 during trading on Monday, hitting $73.72. The stock had a trading volume of 25,802 shares, compared to its average volume of 143,431. LHC Group has a twelve month low of $36.29 and a twelve month high of $76.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.75 and a quick ratio of 1.75. The stock has a market capitalization of $1,312.87, a PE ratio of 32.21, a PEG ratio of 2.18 and a beta of 0.70.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This story was reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://www.com-unik.info/2017/11/06/lhc-group-lhcg-issues-earnings-results.html.

A number of brokerages have weighed in on LHCG. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $75.00 price objective on shares of LHC Group in a research note on Friday. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Robert W. Baird reiterated a “hold” rating and issued a $63.00 price objective on shares of LHC Group in a research note on Tuesday, September 12th. Royal Bank Of Canada reiterated a “buy” rating and issued a $70.00 price objective on shares of LHC Group in a research note on Wednesday, September 6th. Finally, Bank of America Corporation began coverage on LHC Group in a research note on Monday, August 21st. They issued a “buy” rating and a $76.00 price objective for the company. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. LHC Group currently has an average rating of “Buy” and a consensus price target of $68.50.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History for LHC Group (NASDAQ:LHCG)

What are top analysts saying about LHC Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LHC Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit